Cullinan Associates Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 27.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,398 shares of the healthcare conglomerate's stock after selling 3,990 shares during the quarter. Cullinan Associates Inc.'s holdings in UnitedHealth Group were worth $3,244,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of UNH. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of UnitedHealth Group by 6.0% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 3,729 shares of the healthcare conglomerate's stock valued at $1,953,000 after acquiring an additional 211 shares in the last quarter. RDA Financial Network raised its holdings in shares of UnitedHealth Group by 3.4% during the first quarter. RDA Financial Network now owns 9,282 shares of the healthcare conglomerate's stock valued at $4,861,000 after acquiring an additional 304 shares in the last quarter. Finally, ARS Wealth Advisors Group LLC grew its stake in UnitedHealth Group by 3.6% in the first quarter. ARS Wealth Advisors Group LLC now owns 28,650 shares of the healthcare conglomerate's stock worth $15,005,000 after purchasing an additional 1,004 shares during the period. Institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the company. Royal Bank Of Canada reduced their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Truist Financial increased their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Oppenheimer lowered their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, KeyCorp decreased their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $358.95.
Check Out Our Latest Report on UNH
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock opened at $360.17 on Monday. The stock has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50 day moving average price of $307.84 and a 200-day moving average price of $353.45. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.